ligand-efficient inhibitors (AstraZeneca Pharmaceuticals/Adelphi University)

N/A

Report date: 2025/06/11 10:54:49
NME

Base Information

Drug Nameligand-efficient inhibitors (AstraZeneca Pharmaceuticals/Adelphi University)
Drug Alias NameAU-020AU-001AU-230
ClassificationSmall molecules
Mechanisms of ActionHydrolases inhibitorsAdenosine modulators
TargetsHydrolases
Therapy Area/IndicationsTrichomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Pharmaceuticals Lp
China Registration ClassN/A

Develop Information

Active CompaniesAdelphi UniversityAstrazeneca Pharmaceuticals Lp
Inactive CompaniesN/A
Active IndicationsTrichomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A